NYSE · Financial Statements

Fresenius Medical Care AG & Co. KGaA (FMS) Financial Statements

$23.69 NYSE: FMS Market Cap $12.72B

Fresenius Medical Care AG & Co. KGaA most recently reported annual revenue of $19.6B, net profit of $978.0M. Revenue grew at an average annual rate of 1.9% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Fresenius Medical Care AG & Co. KGaA: Revenue rose from $17.0B in 2016 to $19.6B in 2025, a change of +15.3% over 9 years; net profit was positive in all 10 reported years; operating margin moved from 14.7% to 9.3%, a shift of -5.4 percentage points; the most recent year shows net profit of $978.0M.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$17.0B$17.8B$16.5B$17.5B$17.9B$17.6B$19.4B$19.5B$19.3B$19.6B
Operating Expenses$14.5B$15.4B$13.5B$15.2B$15.6B$15.8B$17.9B$18.1B$17.9B$17.8B
Operating Profit$2.5B$2.4B$3.0B$2.3B$2.3B$1.9B$1.5B$1.4B$1.5B$1.8B
Operating Margin14.7%13.3%18.4%13.0%12.9%10.5%7.8%7.0%7.6%9.3%
Other Income$-363.0M$-365.0M$-301.0M$-429.0M$-368.0M$-280.0M$-292.0M$-336.0M$-410.0M$-315.0M
Interest$427.0M$416.0M$448.0M$491.0M$410.0M$354.0M$360.0M$425.0M$407.0M$384.0M
Depreciation$702.0M$735.0M$725.0M$1.6B$1.8B$1.6B$1.8B$1.8B$1.7B$1.5B
Profit Before Tax$2.1B$2.0B$2.7B$1.8B$1.9B$1.6B$1.2B$1.0B$1.1B$1.5B
Tax$30.6M$22.6M$18.7M$21.8M$25.9M$22.4M$26.6M$29.1M$29.9M$21.2M
Net Profit$1.2B$1.3B$2.0B$1.2B$1.2B$969.0M$673.0M$499.0M$538.0M$978.0M
EPS$1.87$2.08$3.23$1.35$1.31$0.83$0.57$0.85$0.92$1.68
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricJun '23Sep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue$4.8B$4.9B$5.0B$4.7B$4.8B$4.8B$5.1B$4.9B$4.8B$4.9B$5.1B$4.6B
Operating Expenses$4.5B$4.6B$4.6B$4.5B$4.3B$4.3B$4.7B$4.5B$4.4B$4.4B$4.5B$4.2B
Operating Profit$357.0M$324.0M$428.0M$246.0M$425.0M$463.0M$399.0M$382.0M$394.0M$502.0M$549.0M$376.0M
Operating Margin7.4%6.6%8.6%5.2%8.9%9.7%7.8%7.8%8.2%10.3%10.8%8.1%
Interest$105.0M$114.0M$111.0M$104.0M$103.0M$99.0M$101.0M$96.0M$97.0M$93.0M$99.0M$93.0M
Profit Before Tax$276.0M$235.0M$343.0M$158.0M$340.0M$381.0M$179.0M$251.0M$351.0M$403.0M$508.0M$208.0M
Tax$29.4M$37.5M$25.2M$25.0M$29.1M$30.6M$34.1M$24.4M$22.3M$18.7M$20.9M$20.6M
Net Profit$140.0M$84.0M$188.0M$71.0M$187.0M$213.0M$67.0M$151.0M$225.0M$275.0M$327.0M$118.0M
EPS$0.16$0.10$0.22$0.06$0.16$0.19$0.06$0.26$0.39$0.47$0.57$0.22

Over the 10 years reported for Fresenius Medical Care AG & Co. KGaA, borrowings increased from $8.1B in 2016 to $10.8B in 2025, cash stood at $1.6B in the latest year, shareholders' equity was $14.3B, current assets covered current liabilities 1.26 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$25.5B$24.0B$26.2B$32.9B$31.7B$34.4B$35.8B$33.9B$33.6B$31.0B
Current Assets$6.9B$6.4B$7.8B$7.2B$7.3B$8.0B$8.2B$8.7B$7.9B$7.9B
Cash$709.0M$978.0M$2.1B$1.0B$1.1B$1.5B$1.3B$1.4B$1.2B$1.6B
Inventory$1.3B$1.3B$1.5B$1.7B$1.9B$2.0B$2.3B$2.2B$2.1B$2.1B
Receivables$3.7B$3.5B$3.4B$3.6B$3.3B$3.6B$3.7B$3.6B$3.4B$3.1B
Fixed Assets$3.6B$3.5B$3.8B$8.5B$8.2B$8.6B$8.3B$7.5B$7.3B$3.0B
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$864.0M$662.0M$769.0M$852.0M$940.0M$946.0M$1.4B$1.2B$1.3B$0
Other Assets$13.0B$12.1B$12.2B$14.0B$13.0B$14.4B$15.8B$14.7B$15.2B$0
Total Liabilities$14.5B$13.2B$13.3B$19.7B$19.4B$20.4B$20.3B$19.1B$17.8B$16.7B
Current Liabilities$5.3B$5.3B$6.3B$7.1B$6.1B$7.3B$6.5B$6.1B$5.7B$6.2B
Borrowings$8.1B$7.5B$7.6B$13.8B$12.4B$13.3B$13.2B$12.1B$11.0B$10.8B
Other Liabilities$6.3B$5.7B$5.8B$5.9B$7.0B$7.1B$7.1B$7.0B$6.8B$5.9B
Equity$361.0M$308.0M$308.0M$304.0M$293.0M$293.0M$293.0M$293.0M$293.0M$14.3B
Reserves$10.0B$9.8B$11.8B$12.0B$11.2B$12.7B$14.0B$13.6B$14.6B$14.3B

For Fresenius Medical Care AG & Co. KGaA, operating cash flow was positive in 10 of 10 reported years; free cash flow in the latest year was $1.7B; free cash flow was positive in 10 of 10 years; financing activities used $1.7B in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow$2.0B$2.2B$2.1B$2.6B$4.2B$2.5B$2.2B$2.6B$2.4B$2.6B
Investing Cash Flow$-3.3B$-2.8B$-2.3B$-4.4B$-2.4B$-2.1B$-1.5B$-1.2B$-784.0M$-1.5B
Financing Cash Flow$273.0M$-196.0M$-518.0M$-431.0M$-1.0B$-273.0M$-104.0M$-340.0M$-315.0M$-1.7B
Net Cash Flow$188.0M$269.0M$1.2B$-1.1B$74.0M$400.0M$-208.0M$153.0M$-242.0M$558.0M
Free Cash Flow$93.0M$407.0M$2.0M$1.4B$3.2B$1.6B$1.4B$1.9B$1.7B$1.7B

Valuation & Return Ratios

MetricValue
PEG Ratio0.23
EV / EBITDA6.03
FCF Yield16.03%
Quick Ratio0.86
Interest Coverage5.15
Return 1Y-17.73%
Return 3Y36.35%
Return 5Y-30.16%

Fresenius Medical Care AG & Co. KGaA (FMS) financials — frequently asked questions

What is Fresenius Medical Care AG & Co. KGaA's annual revenue?

Fresenius Medical Care AG & Co. KGaA (FMS) reported annual revenue of $19.6B in its most recent fiscal year.

What is Fresenius Medical Care AG & Co. KGaA's net profit?

Fresenius Medical Care AG & Co. KGaA (FMS) reported net profit of $978.0M in its most recent fiscal year.

What is FMS EV/EBITDA?

Fresenius Medical Care AG & Co. KGaA's enterprise value to EBITDA (EV/EBITDA) ratio is 6.03.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
FMS Overview FMS Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.